Assumption:
HDX labs was filed and created immediately after Finra news denied RSHN approval for any corporate actions. The timing is anything but sus.
It was also created as another laboratory shortly after the debt restructuring tied HeliosDx to pay back the 4.5M in debt changed and was based on revenue.
It seems like moving business to HDX that would be HeliosDx revenue could be easily done, since the controlling shareholder appears to be the same.
Why create a private laboratory when you are operating a public one in the first place?
During the same time period, HDX is being claimed to stay a "private company" during the HeliosDx "process".
But what is the purpose of HDX, what do they do, how is revenue split between HDX and HeliosDx, and is HDX a subsidiary of HeliosDx?
The assumption is they want to move HeliosDx debt to HDX balance sheet in the form of share distribution and ownership. That it is not a subsidiary or owned by HeliosDx.
The "debt buyout" probably hinges on the preferred and common owned by management of RSHN, or the 5B they are trying to dilute through the SEC. This will not be a cash transaction.
This type of deal is shady at best. Of course there could be an alternative in the works, but if it were a clean cut deal it would have already been announced and executed several weeks ago.
My guess is a hold up in approvals in legal and/or filings that are questioning it (as they did with Finra and the spin out) and it eventually leads to another denial and failure.
Just an assumption, but seems very possible with the current track record.
Horrible
Market Data 
Markets 
AI
